Literature DB >> 16165251

NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.

Nathalie Evrard-Todeschi1, Josyane Gharbi-Benarous, Gildas Bertho, Gaël Coadou, Simon Megy, Richard Benarous, Jean-Pierre Girault.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Vpu enhances viral particle release and, its interaction with the ubiquitin ligase SCF-beta-TrCP triggers the HIV-1 receptor CD4 degradation by the proteasome. The interaction between beta-TrCP protein and ligands containing the phosphorylated DpSGXXpS motif plays a key role for the development of severe disease states, such as HIV or cancer. This study examines the binding and conformation of phosphopeptides (P1, LIERAEDpSG and P2, EDpSGNEpSE) from HIV protein Vpu to beta-TrCP with the objective of defining the minimum length of peptide needed for effective binding. The screening step can be analyzed by NMR spectroscopy, in particular, saturation transfer NMR methods clearly identify the residues in the peptide that make direct contact with beta-TrCP protein when bound. An analysis of saturation transfer difference (STD) spectra provided clear evidence that the two peptides efficiently bound beta-TrCP receptor protein. To better characterize the ligand-protein interaction, the bound conformation of the phosphorylated peptides was determined using transferred NOESY methods, which gave rise to a well-defined structure. P1 and P2 can fold in a bend arrangement for the DpSG motif, showing the protons identified by STD-NMR as exposed in close proximity at the molecule surface. Ser phosphorylation allows electrostatic interaction and hydrogen bond with the amino acids of the beta-TrCP binding pocket. The upstream LIER hydrophobic region was also essential in binding to a hydrophobic pocket of the beta-TrCP WD domain. These findings are in good agreement with a recently published X-ray structure of a shorter beta-Catenin fragment with the beta-TrCP complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165251     DOI: 10.1016/j.peptides.2005.07.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  The Vpu protein: new concepts in virus release and CD4 down-modulation.

Authors:  Autumn Ruiz; John C Guatelli; Edward B Stephens
Journal:  Curr HIV Res       Date:  2010-04       Impact factor: 1.581

Review 2.  Relating structure and function of viral membrane-spanning miniproteins.

Authors:  Stanley J Opella
Journal:  Curr Opin Virol       Date:  2015-06-06       Impact factor: 7.090

3.  Proteomic screening method for phosphopeptide motif binding proteins using peptide libraries.

Authors:  Heather R Christofk; Ning Wu; Lewis C Cantley; John M Asara
Journal:  J Proteome Res       Date:  2011-08-02       Impact factor: 4.466

4.  Structural determination of virus protein U from HIV-1 by NMR in membrane environments.

Authors:  Hua Zhang; Eugene C Lin; Bibhuti B Das; Ye Tian; Stanley J Opella
Journal:  Biochim Biophys Acta       Date:  2015-09-08

5.  Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells.

Authors:  Peter W Ramirez; Marylinda Famiglietti; Bharatwaj Sowrirajan; Ana Beatriz DePaula-Silva; Christopher Rodesch; Edward Barker; Alberto Bosque; Vicente Planelles
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

Review 6.  Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.

Authors:  Peter W Ramirez; Shilpi Sharma; Rajendra Singh; Charlotte A Stoneham; Thomas Vollbrecht; John Guatelli
Journal:  Cells       Date:  2019-09-02       Impact factor: 6.600

Review 7.  Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.

Authors:  Nabab Khan; Jonathan D Geiger
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

8.  Prediction of HIV-1 virus-host protein interactions using virus and host sequence motifs.

Authors:  Perry Evans; William Dampier; Lyle Ungar; Aydin Tozeren
Journal:  BMC Med Genomics       Date:  2009-05-18       Impact factor: 3.063

9.  Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.

Authors:  Ilias Christodoulopoulos; Magali E Droniou-Bonzom; Jill E Oldenburg; Paula M Cannon
Journal:  Retrovirology       Date:  2010-01-26       Impact factor: 4.602

10.  Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Authors:  Richard S Mitchell; Chris Katsura; Mark A Skasko; Katie Fitzpatrick; David Lau; Autumn Ruiz; Edward B Stephens; Florence Margottin-Goguet; Richard Benarous; John C Guatelli
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.